文献速递消化道肿瘤与早癌

长链非编码RNA CCAT2通过BOP1-AURKB信号诱导染色体不稳定性

The Long Noncoding RNA CCAT2 Induces Chromosomal Instability Through BOP1-AURKB Signaling.
PubMed 文献 · Gastroenterology · 2020-08-15

该研究在结直肠癌细胞系、小鼠类器官及转基因小鼠中发现,CCAT2长链非编码RNA高表达可诱导染色体不稳定性并增加对5-氟尿嘧啶和奥沙利铂的抵抗。机制上,CCAT2直接结合并稳定BOP1,BOP1通过增加aurora kinase B活性形式促进染色体错误分离。在超过900例患者的5个队列中,微卫星稳定肿瘤中CCAT2与BOP1均升高且与较短生存相关。

要点

  • CCAT2高表达诱导结直肠癌细胞染色体不稳定性并增加化疗抵抗。
  • CCAT2直接结合并稳定BOP1,BOP1通过增加aurora kinase B活性形式促进染色体不稳定性。
  • 微卫星稳定肿瘤中CCAT2与BOP1升高且互相关联,并与较短生存相关。

核心结论

  • 结肠细胞中CCAT2过表达通过稳定并诱导BOP1表达促进染色体不稳定性和癌变,BOP1为aurora kinase B的激活因子。
  • 靶向该通路或可为微卫星稳定结直肠肿瘤患者的治疗提供策略。

研究设计与样本

  • 对过表达CCAT2的结直肠癌细胞系(HCT116、KM12C/SM和HT29)及携带CCAT2转基因与无转基因对照的C57BL/6N小鼠结肠类器官进行细胞遗传学分析。
  • 给予CCAT2转基因与对照小鼠氧化偶氮甲烷和葡聚糖硫酸钠以诱导结肠肿瘤。
  • 采用基因表达芯片与质谱检测CCAT2 lncRNA下游靶点,并用MS2 pull-down、RNA免疫沉淀和选择性2'-羟基酰化引物延伸分析表征CCAT2与下游蛋白的相互作用。
  • 在结直肠癌细胞中过表达下游蛋白并分析染色体不稳定性。
  • 在5个队列、超过900例患者的结直肠癌与非肿瘤组织中检测基因表达水平。

主要发现

  • CCAT2高表达在结直肠癌细胞系中诱导染色体不稳定性并增加对5-氟尿嘧啶和奥沙利铂的抵抗。
  • 表达CCAT2转基因的小鼠发生染色体异常,其隐窝细胞来源的结肠类器官染色体异常百分比较对照小鼠类器官更高。
  • 给予氧化偶氮甲烷和葡聚糖硫酸钠的转基因小鼠较对照小鼠发生更多且更大的结肠息肉。
  • 芯片与质谱分析提示CCAT2表达增加核糖体生物合成和蛋白合成相关基因表达,CCAT2 lncRNA直接结合并稳定BOP1核糖体生物合成因子(BOP1),CCAT2还增加MYC表达而MYC激活BOP1表达。
  • 结直肠癌细胞系中过表达BOP1导致染色体错误分离、增加集落形成和侵袭性,而敲低BOP1降低活力;BOP1通过增加aurora kinase B活性形式促进染色体不稳定性,且BOP1在CCAT2转基因小鼠息肉组织中较健康组织过表达。

临床怎么用

  • 作者认为靶向该通路的策略或可开发用于微卫星稳定结直肠肿瘤患者的治疗。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Chromosomal instability (CIN) is a carcinogenesis event that promotes metastasis and resistance to therapy by unclear mechanisms. Expression of the colon cancer-associated transcript 2 gene (CCAT2), which encodes a long noncoding RNA (lncRNA), associates with CIN, but little is known about how CCAT2 lncRNA regulates this cancer enabling characteristic. METHODS: We performed cytogenetic analysis of colorectal cancer (CRC) cell lines (HCT116, KM12C/SM, and HT29) overexpressing CCAT2 and colon organoids from C57BL/6N mice with the CCAT2 transgene and without (controls). CRC cells were also analyzed by immunofluorescence microscopy, γ-H2AX, and senescence assays. CCAT2 transgene and control mice were given azoxymethane and dextran sulfate sodium to induce colon tumors. We performed gene expression array and mass spectrometry to detect downstream targets of CCAT2 lncRNA. We characterized interactions between CCAT2 with downstream proteins using MS2 pull-down, RNA immunoprecipitation, and selective 2'-hydroxyl acylation analyzed by primer extension analyses. Downstream proteins were overexpressed in CRC cells and analyzed for CIN. Gene expression levels were measured in CRC and non-tumor tissues from 5 cohorts, comprising more than 900 patients. RESULTS: High expression of CCAT2 induced CIN in CRC cell lines and increased resistance to 5-fluorouracil and oxaliplatin. Mice that expressed the CCAT2 transgene developed chromosome abnormalities, and colon organoids derived from crypt cells of these mice had a higher percentage of chromosome abnormalities compared with organoids from control mice. The transgenic mice given azoxymethane and dextran sulfate sodium developed more and larger colon polyps than control mice given these agents. Microarray analysis and mass spectrometry indicated that expression of CCAT2 increased expression of genes involved in ribosome biogenesis and protein synthesis. CCAT2 lncRNA interacted directly with and stabilized BOP1 ribosomal biogenesis factor (BOP1). CCAT2 also increased expression of MYC, which activated expression of BOP1. Overexpression of BOP1 in CRC cell lines resulted in chromosomal missegregation errors, and increased colony formation, and invasiveness, whereas BOP1 knockdown reduced viability. BOP1 promoted CIN by increasing the active form of aurora kinase B, which regulates chromosomal segregation. BOP1 was overexpressed in polyp tissues from CCAT2 transgenic mice compared with healthy tissue. CCAT2 lncRNA and BOP1 mRNA or protein were all increased in microsatellite stable tumors (characterized by CIN), but not in tumors with microsatellite instability compared with nontumor tissues. Increased levels of CCAT2 lncRNA and BOP1 mRNA correlated with each other and with shorter survival times of patients. CONCLUSIONS: We found that overexpression of CCAT2 in colon cells promotes CIN and carcinogenesis by stabilizing and inducing expression of BOP1 an activator of aurora kinase B. Strategies to target this pathway might be developed for treatment of patients with microsatellite stable colorectal tumors.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Chen B, Dragomir MP, Fabris L, et al. The Long Noncoding RNA CCAT2 Induces Chromosomal Instability Through BOP1-AURKB Signaling. Gastroenterology. 2020. PMID: 32805281. doi:10.1053/j.gastro.2020.08.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。